医学
内科学
内分泌学
糖尿病
免疫系统
免疫学
2型糖尿病
二肽基肽酶-4抑制剂
炎症
联合疗法
作者
Marcelo Maia Pinheiro,Felipe Moura Maia Pinheiro,Susana Nogueira Diniz,Andrea Fabbri,Marco Infante
标识
DOI:10.1016/j.intimp.2021.107518
摘要
Type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA) represent the most common types of autoimmune diabetes and are characterized by different age of onset, degrees of immune-mediated destruction of pancreatic beta cells and rates of disease progression towards insulin dependence. Several immunotherapies aimed to counteract autoimmune responses against beta cells and preserve beta-cell function are currently being investigated, particularly in T1D. Preliminary findings suggest a potential role of combination therapy with vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors (VIDPP-4i) in preserving beta-cell function in autoimmune diabetes. This manuscript aims to provide a comprehensive overview of the immunomodulatory properties of vitamin D and DPP-4 inhibitors, as well as the rationale for investigation of their combined use as an immunomodulation therapy for autoimmune diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI